Published in Am J Surg on May 01, 1981
Management of bleeding esophageal varices. West J Med (1982) 1.40
A systematic appraisal of portacaval H-graft diameters. Clinical and hemodynamic perspectives. Ann Surg (1986) 0.98
Hepatic encephalopathy verified by psychometric testing and EEG in cirrhotic patients: effects of mesocaval interposition shunt or sclerotherapy. HPB (Oxford) (2005) 0.75
Selective trans-splenic decompression of gastroesophageal varices by distal splenorenal shunt. Ann Surg (1967) 5.62
A randomized, controlled trial of the distal splenorenal shunt. Ann Surg (1978) 2.15
Asymmetric methylation in the hypermethylated CpG promoter region of the human L1 retrotransposon. J Biol Chem (1997) 1.89
Ten years portal hypertensive surgery at Emory. Results and new perspectives. Ann Surg (1982) 1.78
Selective and total shunts in the treatment of bleeding varices. A randomized controlled trial. N Engl J Med (1976) 1.77
Endoscopic variceal sclerosis compared with distal splenorenal shunt to prevent recurrent variceal bleeding in cirrhosis. A prospective, randomized trial. Ann Intern Med (1990) 1.75
Selective distal splenorenal shunt. Technique and results of operation. Arch Surg (1974) 1.74
Angiography in portal hypertension: clinical significance in surgery. Am J Surg (1980) 1.72
Distal splenorenal shunt versus endoscopic sclerotherapy for long-term management of variceal bleeding. Preliminary report of a prospective, randomized trial. Ann Surg (1986) 1.62
Hemodynamic contrasts between selective and total portal-systemic decompression. Ann Surg (1971) 1.58
Pancreatic ascites: diagnosis and management with particular reference to surgical technics. Ann Surg (1973) 1.53
The Emory prospective randomized trial: selective versus nonselective shunt to control variceal bleeding. Ten year follow-up. Ann Surg (1985) 1.50
Hermes, a functional non-Drosophilid insect gene vector from Musca domestica. Genetics (1996) 1.47
Hemodynamic differences between alcoholic and nonalcoholic cirrhotics following distal splenorenal shunt--effect on survival? Ann Surg (1983) 1.42
Maximal rates of excretion and synthesis of urea in normal and cirrhotic subjects. J Clin Invest (1973) 1.32
Further evaluation of selective decompression of varices by distal splenorenal shunt. Ann Surg (1969) 1.30
Preoperative assessment of portal hypertension. Ann Surg (1967) 1.28
STAT6 is required for IL-4-induced germline Ig gene transcription and switch recombination. J Immunol (1998) 1.27
The hobo transposable element of Drosophila can be cross-mobilized in houseflies and excises like the Ac element of maize. Proc Natl Acad Sci U S A (1993) 1.25
Reversal of hepatic encephalopathy after occlusion of total portasystemic shunts. Am J Surg (1981) 1.22
The metabolic basis of portasystemic encephalopathy and the effect of selective vs nonselective shunts. Ann Surg (1974) 1.19
Prevention of postoperative hemorrhage after pancreatic cystogastrostomy. Ann Surg (1973) 1.17
Selective variceal decompression after splenectomy or splenic vein thrombosis. With a note on splenopancreatic disconnection. Ann Surg (1984) 1.10
Rerouting arterial flow to relieve ischemia: femoro-femoral, axillary femoral and carotid-carotid artery bypasses. Ann Surg (1966) 1.10
Dacron interposition shunts for portal hypertension. An analysis of morbidity correlates. Ann Surg (1980) 1.09
Noncirrhotic portal vein thrombosis. Physiology before and after shunts. Ann Surg (1980) 1.08
Restoration of portal venous perfusion and reversal of encephalopathy by balloon occlusion of portal systemic shunt. Gastroenterology (1984) 1.07
Distal splenorenal shunt in treatment of bleeding esophageal varices in renal transplant recipients. Surg Gynecol Obstet (1984) 1.07
Vascular physiology in portal hypertension with ascites. Clinical and experimental studies and role of portocaval shunt. Ann Surg (1966) 1.04
Interplasmid transposition of Drosophila hobo elements in non-drosophilid insects. Mol Gen Genet (1994) 1.04
End renal vein-to-splenic vein shunts for total or selective portal decompression. Surgery (1972) 1.03
Effect of peritoneovenous shunting with the Le Veen valve on ascites, renal function, and coagulation in six patients with intractable ascites. Surgery (1978) 1.03
Portal pseudoperfusion: an angiographic illusion. Ann Surg (1979) 1.02
Surgical significance of differentiation between acute and chronic pancreatic collections. Ann Surg (1969) 1.00
Fat assimilation after massive distal pancreatectomy. N Engl J Med (1968) 1.00
Control of variceal bleeding. Reassessment of rationale. Am J Surg (1983) 1.00
Genetic and morphological study of aggregation in the cellular slime mold Polysphondylium violaceum. Genetics (1976) 0.97
Splenic vein thrombosis: a diagnosable and curable form of portal hypertension. Surgery (1973) 0.97
Genetic complexity of aggregation in the cellular slime mold Polysphondylium violaceum. Proc Natl Acad Sci U S A (1975) 0.96
The transposable element mariner can excise in non-drosophilid insects. Mol Gen Genet (1995) 0.96
Approach to the spectrum of Budd-Chiari syndrome: which patients require portal decompression? Am J Surg (1985) 0.95
A hypercoagulable state follows orthotopic liver transplantation. Hepatology (1990) 0.94
Splenopancreatic disconnection. Improved selectivity of distal splenorenal shunt. Ann Surg (1986) 0.94
Presidential address. Not for the profession . . . for the people. Ann Surg (1983) 0.93
Splenectomy is contraindicated for thrombocytopenia secondary to portal hypertension. Surg Gynecol Obstet (1985) 0.91
Breast reconstruction: a plea for saving the uninvolved nipple. Am J Surg (1971) 0.91
Hemodynamic studies in portal hypertension. Annu Rev Med (1969) 0.91
Portaprival collaterals following distal splenorenal shunt. Incidence, magnitude and associated portal perfusion changes. J Hepatol (1985) 0.90
Pancreatoduodenectomy for trauma: clinical and metabolic studies. Ann Surg (1972) 0.89
Comparison of the effect of various amino acids upon the blood ammonia concentration of patients with liver disease. Am J Clin Nutr (1973) 0.89
The meso-spleno-renal shunt procedures: a comprehensive approach to portasystemic decompression. Ann Surg (1974) 0.88
DNA methylation in mouse A-repeats in DNA methyltransferase-knockout ES cells and in normal cells determined by bisulfite genomic sequencing. Gene (1998) 0.88
A tracer method for measuring rate of urea synthesis in normal and cirrhotic subjects. Gastroenterology (1980) 0.88
Signaling via major histocompatibility complex class II molecules and antigen receptors enhances the B cell response to gp39/CD40 ligand. Eur J Immunol (1995) 0.87
A noninvasive method for measuring portal venous/total hepatic blood flow by hepatosplenic radionuclide angiography. Radiology (1981) 0.87
The incidence and natural history of thrombus in the portal vein following distal splenorenal shunt. Ann Surg (1982) 0.87
Distal splenorenal shunt with splenopancreatic disconnection. A 4-year assessment. Ann Surg (1989) 0.87
DNA methylation in the promoter region of the p16 (CDKN2/MTS-1/INK4A) gene in human breast tumours. Br J Cancer (1999) 0.86
In vivo measurement of leucine metabolism with stable isotopes in normal subjects and in those with cirrhosis fed conventional and branched-chain amino acid-enriched diets. Surgery (1985) 0.86
Angiographic investigations in portal hypertension. Surg Gynecol Obstet (1970) 0.86
The mortality of bleeding esophageal varices in a private university hospital. Am J Surg (1978) 0.86
Change in hepatic function, hemodynamics, and morphology after liver transplant. Physiological effect of therapy. Ann Surg (1989) 0.85
A method of measuring quantitative hepatic function and hemodynamics in cirrhosis: the changes following distal splenorenal shunt. Jpn J Surg (1986) 0.85
Surgical options, hematologic evaluation, and pathologic changes in Budd-Chiari syndrome. Am J Surg (1990) 0.84
Current assessment of the distal splenorenal shunt. South Med J (1975) 0.84
Liver panangiography in the assessment of portal hypertension in liver cirrhosis. Radiol Clin North Am (1970) 0.84
Current status of the distal splenorenal shunt. Semin Liver Dis (1983) 0.84
A denervated pancreatic flap for control of chronic pain in pancreatitis. Surg Gynecol Obstet (1984) 0.84
Radionuclide angiography of the liver and spleen. Noninvasive method for assessing the ratio of portal venous to total hepatic blood flow and portasystemic shunt patency. Am J Surg (1981) 0.84
LeVeen vs Denver peritoneovenous shunts for intractable ascites of cirrhosis. A randomized, prospective trial. Arch Surg (1986) 0.83
Clinical and metabolic response to radical distal pancreatectomy for chronic pancreatitis. Am J Surg (1967) 0.83
The distal splenorenal shunt: an update. World J Surg (1984) 0.83
Cloning and functional expression of human kynurenine 3-monooxygenase. FEBS Lett (1997) 0.82
CD40 expression by gingival fibroblasts: correlation of phenotype with function. Int Immunol (1997) 0.82
The relationship between conventional liver tests, quantitative function tests, and histopathology in cirrhosis. Dig Dis Sci (1979) 0.81
The rate of synthesis of glycosaminoglycans and collagen by fibroblasts cultured from adult human liver biopsies. J Clin Invest (1977) 0.81
Selective variceal decompression: current status and recent advances. Adv Surg (1984) 0.81
Liver shunts. Am J Roentgenol Radium Ther Nucl Med (1968) 0.81
Portal hypertension. Curr Probl Surg (1988) 0.80
Selective variceal decompression in portal vein thrombosis. Br J Surg (1984) 0.80
Increased galactose clearance after liver transplantation: a measure of increased blood flow through the denervated liver? Hepatology (1989) 0.80
Bleeding varices: 1. Emergency management. Can Med Assoc J (1981) 0.80
Integration specificity of the hobo element of Drosophila melanogaster is dependent on sequences flanking the integration site. Genetica (1999) 0.79
Reflections on post-portacaval shunt morbidity. J Cardiovasc Surg (Torino) (1969) 0.79
Endoscopic sclerotherapy for oesophageal varices in children. Br J Surg (1988) 0.79
Two stage surgical management of the Budd-Chiari syndrome associated with obstruction of the inferior vena cava. Surg Gynecol Obstet (1984) 0.79
Splenic artery ligation in distal splenorenal shunts. Am J Surg (1978) 0.79
Small intestinal absorption in the immediate postoperative period. Surgery (1966) 0.79
Evaluation and treatment of early hemorrhage of the alimentary tract after selective shunt procedures. Surg Gynecol Obstet (1987) 0.79
A re-evaluation of lower extremity amputations. Surg Gynecol Obstet (1969) 0.79
Presidential address: reflections on the early development of portacaval shunts. Ann Surg (1980) 0.79
Portal venous-total hepatic flow ratio by radionuclide angiography. J Surg Res (1981) 0.78
Cimetidine does not reduce liver blood flow in cirrhosis. Hepatology (1983) 0.78
The distal splenorenal shunt. Am J Surg (1971) 0.78
Ascites and portasystemic shunts. Am J Surg (1978) 0.78
The dysvascular amputee: surgery and rehabilitation. Curr Probl Surg (1971) 0.78
CD40-CD40 ligand interactions stimulate B cell antigen processing. Eur J Immunol (1995) 0.78
Maintenance of nutritional competence after gastric partitioning for morbid obesity. Am J Surg (1983) 0.78
The effect of topically applied corticosteroids in the prevention of peritoneal adhesions. An experimental approach with a review of the literature. Surgery (1966) 0.77
Recent advances in the management of variceal bleeding. Jpn J Surg (1986) 0.77